All sites C00-96,D32-33,D42-43,D45-47,D76 346 84.8 5.5 3.2 0.6 5.8
Mouth, pharynx C00-14 10 92.2 - 3.9 - 3.9
  Lip C00 1 100.0 - - - -
  Tongue C02 3 80.0 - 6.7 - 13.3
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 3 92.9 - 7.1 - -
Digestive organs C15-26 74 83.1 1.6 5.6 0.5 9.1
  Oesophagus C15 4 77.8 - 11.1 5.6 5.6
  Stomach C16 10 95.8 2.1 - - 2.1
  Small intestine C17 1 85.7 14.3 - - -
  Colon C18 20 98.0 - 1.0 - 1.0
  Rectum, rectosigmoid C19-20 14 94.4 - 4.2 - 1.4
  Anus C21 0 100.0 - - - -
  Liver C22 8 79.5 2.6 2.6 2.6 12.8
  Gallbladder, bile ducts C23-24 2 77.8 - 22.2 - -
  Pancreas C25 14 51.5 2.9 14.7 - 30.9
  Other digestive organs C26 2 12.5 12.5 25.0 - 50.0
Respiratory organs C30-39 44 52.5 30.1 9.1 - 8.2
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 3 92.3 - 7.7 - -
  Lung, trachea C33-34 41 49.8 32.5 9.4 - 8.4
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 15 100.0 - - - -
Skin, non-melanoma C44 10 98.1 1.9 - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 1 100.0 - - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 102 98.2 - - 0.8 1.0
  Prostate C61 99 98.2 - - 0.8 1.0
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 33 91.0 1.2 3.0 - 4.8
  Kidney C64 12 86.4 - 5.1 - 8.5
  Bladder and urinary tract2 C65-68 21 93.5 1.9 1.9 - 2.8
Eye C69 0 50.0 - 50.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 7 85.7 - 11.4 - 2.9
Thyroid gland C73 2 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 8 38.1 9.5 7.1 4.8 40.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 35 80.1 9.1 - 1.7 9.1
  Hodgkin lymphoma C81 2 90.0 10.0 - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 17 98.8 - - - 1.2
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 3 62.5 6.3 - 6.3 25.0
  Leukaemia C91-95 9 64.4 20.0 - 2.2 13.3
  Myelodysplastic syndromes D46 2 8.3 41.7 - 8.3 41.7
  Myeloproliferaitive neoplasms D45,D47 2 100.0 - - - -
Not included above
  Basal cell carcinoma of the skin 81 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.